New medicine test in healthy adults
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests a new medicine called Efsubaglutide Alfa in healthy adults. It is a first-in-human study to see how the drug is absorbed, broken down, and eliminated by the body. This study is for healthy volunteers only, not patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 45 years old.
- You must be a healthy adult, without diabetes or prediabetes.
- Your body mass index (BMI) must be between 18 and 28.
- You must not have a history of certain medical conditions like pancreatitis, heart problems, or thyroid tumors.
- You must not have taken any medications (including over-the-counter) in the past 12 months.
- You must agree to use effective birth control during the study and for 3 months after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational shot (given every two weeks) that may help lower blood sugar in people with type 2 diabetes. Participation involves regular check-ups and blood tests to see how well the treatment works for you.
This study tests a new weekly injection, efsubaglutide alfa (a GLP-1 drug), for helping people with overweight or obesity lose weight. It is for people who have not been able to lose weight with diet and exercise alone and do not have other serious health conditions.
This trial tests an injection called efsubaglutide alfa to help obese teenagers lose weight. It requires following diet and exercise advice for at least 3 months before starting.
This study tests how three common diabetes medicines (dapagliflozin, linagliptin, and metformin) are absorbed when taken with food in healthy adults. It helps doctors understand safe dosing and potential interactions.
This study tests a new medicine, NNC0662-0419, in people with type 2 diabetes. You must be willing to lose a lot of weight (more than a quarter of your current weight) as part of the study to see if the medicine helps lower blood sugar.
This study tests a new medicine called HS-20094 for people with type 2 diabetes. It aims to see if it helps lower blood sugar and may also help with weight. You may be able to join if you are currently on metformin or metformin plus an SGLT-2 inhibitor.
Hear when a new Diabete Type 2 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.